April 14, 2021
Webinar
Preliminary due diligence searching and investigations complete, and material supplied reviewed. What are the next steps in assessing the portfolio to be bought or sold to guarantee the best value for the buyer/seller? As in Part I, the process will be discussed from the standpoint of both the seller and the acquirer of the portfolio, and we will discuss both U.S. and European considerations.
Topics to be discussed include:
Moderator:
Sarah Rodriguez
Speakers:
Clare Cornell
Amanda Murphy
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
WTR Live: Brand Strategy Summit Europe 2024
March 12-13, 2024
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.